S-Metoprolol XR 25-50 mg Tablets vs Metoprolol Zok 50-100 mg Tablets in Hypertension Patients.
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 126 participants.
Also called NCT04457323
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 126 participants
- Sponsor
- Neutec Ar-Ge San ve Tic A.Ş
- Registry
-
NCT04457323
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT04457323. Randomized; double masking; primary purpose treatment. Start 2022-01-15 (anticipated); primary completion 2022-10-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- S-Metoprolol XR 25-50 mg Tablets vs Metoprolol Zok 50-100 mg Tablets in Hypertension Patients.
- Condition
- Hypertension
- Intervention (Drug)
- Metoprolol
- Intervention (Drug)
- Metoprolol
- Lead sponsor
- Neutec Ar-Ge San ve Tic A.Ş
Record details
- Record id
cardio:ct-nct04457323- Content hash
1018927ef520678b726231bd41f1f5a40d72a8c2bf657969db524f7f5d40547b